Page last updated: 2024-08-17

levodopa and Psychoses

levodopa has been researched along with Psychoses in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	17 (27.42)	18.7374
1990's	6 (9.68)	18.2507
2000's	15 (24.19)	29.6817
2010's	15 (24.19)	24.3611
2020's	9 (14.52)	2.80

Authors

Authors	Studies
Gourdon, JC; Huot, P; Maddaford, S; Nuara, SG	1
Hong, PK; Leey, TC; Ling, TC; Semilan, SLA; Sivanandy, P; Wey Han, SA; Xiang, TC	1
Fung, VSC; Griffith, J; Qiu, J; Tsui, D; Waller, S; Williams, L	1
Bishop, C; Centner, A; Cohen, S; Glinski, J; Lipari, N; Manfredsson, FP	1
Alakkas, A; Liu, L; Longardner, K; Nahab, FB; Wright, BA; Xu, R; You, H	1
Bédard, D; Frouni, I; Gourdon, JC; Hamadjida, A; Huot, P; Kang, W; Kwan, C; Nuara, SG	1
Haker, H; Rössler, J; Rössler, W; Seifritz, E; Unterrassner, L; Wotruba, D; Wyss, T	1
Abbasi, MH; Esmaeili, S; Habibi, SA; Shahidi, GA	1
Gourdon, JC; Huot, P; Kwan, C; Nuara, SG	1
Gourdon, JC; Hamadjida, A; Huot, P; Nuara, SG	1
Bastiampillai, T; Chuck, W; Dhillon, R; Okungu, A; Tibrewal, P	1
Beck, JP; Bruns, RF; Carter, G; Chernet, E; Eastwood, BJ; Falcone, JF; Hao, J; Harper, AJ; Katner, JS; Li, X; Love, PL; Maren, DL; Masquelin, ME; Menezes, MM; Mitchell, SN; Murray, TK; O'Neill, MJ; Ryder, JW; Schaus, JM; Shanks, EA; Svensson, KA; Thompson, LK; Wafford, KA; Wang, H; Witkin, JM; Yang, CR; Zhang, L	1
Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Sudoh, S; Sugiyama, H; Tomita, S; Umemura, A; Yamamoto, K	1
Akbar, U; Fayad, SM; Hack, N; Hardwick, A; Malaty, IA; McFarland, N; Monari, EH; Okun, MS; Rodriguez, RL; Romrell, J; Wagle Shukla, AA; Ward, HE	1
Behr, J; Boehme, R; Buchert, R; Deserno, L; Gleich, T; Heinz, A; Katthagen, T; Pankow, A; Roiser, JP; Schlagenhauf, F	1
Baas, H; Gerlach, M; Kassubek, J; Müller, T; Reichmann, H; Riederer, P; Schrader, C; Urban, PP; Woitalla, D	1
Espay, AJ; Fasano, A; Ricciardi, L	1
Cannas, A; Marrosu, F; Meloni, M; Solla, P	1
Chang, MH; Chen, YH; Lee, WJ; Lin, CH; Wu, YH	1
Stahl, SM	1
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D	1
Moncrieff, J	1
Bachoud-Lévi, AC; Cleret de Langavant, L; Fénelon, G; Soulas, T; Trinkler, I	1
Arai, H; Doi, N; Hatta, K; Hattori, N; Kamigaichi, R; Kubo, S; Nakamura, H; Nakanishi, A; Usui, C	1
Bugalho, P; Cargaleiro, I; da Silva, JA; Neto, B; Serra, M	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Djaldetti, R; Melamed, E	1
Burke, MA; Fernandez, HH; Friedman, JH; Jacques, C; Trieschmann, ME	1
Fénelon, G; Goetz, CG; Karenberg, A	1
Anderson, KE; Salter, BC; Weiner, WJ	1
Duda, JE; Moberg, PJ; Morales, KH; Stern, MB; Weintraub, D	1
Bernardi, S; Meco, G	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V	1
Archer, T; Fredriksson, A	1
Stewart, JT	1
Muthane, U; Ragothaman, M	1
Itoh, H	1
Giampietro, AC; Karniol, IG; Moura, DS; Oliveira, MA; Vilela, WA; Zuardi, AW	1
Bellizzi, J; Hale, MS	1
Danielczyk, W	1
Greene, P	1
Caligiuri, MP	1
Helscher, RJ; Pinter, MM	1
Bassi, A; Cicardi, MC; Loberti, M; Pierantozzi, M; Semprini, R; Stanzione, P; Traversa, R	1
Bowers, MB	1
Seeman, P; Tallerico, T	1
Giladi, N; Kandinov, B; Korczyn, AD; Orlov, Y; Paleacu, D; Shabtai, H; Simon, ES; Treves, TA	1
Masson, C	1
Becker, G; Beckmann, H; Berg, D; Jabs, B; Merschdorf, U	1
Costentin, J	1
Fann, WE; Stafford, JR	1
Klawans, H	1
Anokhina, IP; Kudriavtsev, IA; Lukacher, GIa; Morozov, GV; Morozova, TG	1
Hausner, R	1
Dolezalová, B; Vacek, J	1
Capone, D; Ombrato, M	1
Hashimoto, H; Hasui, M; Igarashi, N; Kato, E; Minami, S; Okabe, T; Sato, T	1
Fahn, S	1
Neppe, VM	1
Hardie, RJ; Lees, AJ	1
Harris, M; Nora, L; Tanner, CM	1
Harvey, NS	1

Reviews

13 review(s) available for levodopa and Psychoses

Article	Year
Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson's Symptoms. International journal of environmental research and public health, 2021, 12-30, Volume: 19, Issue:1 Topics: Antiparkinson Agents; Humans; Levodopa; Parkinson Disease; Pharmaceutical Preparations; Psychotic Disorders; United States	2021
Laboratory assessments in the course of Parkinson's disease: a clinician's perspective. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:1 Topics: Clinical Laboratory Techniques; Confusion; Dementia; Diagnosis, Differential; Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Vitamins	2016
Treatment of early Parkinson's disease. Part 2. European neurology, 2009, Volume: 61, Issue:4 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors	2009
A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard review of psychiatry, 2009, Volume: 17, Issue:3 Topics: Antipsychotic Agents; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Humans; Levodopa; Models, Neurological; Psychotic Disorders; Schizophrenia	2009
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
New drugs in the future treatment of Parkinson's disease. Journal of neurology, 2002, Volume: 249 Suppl 2 Topics: Animals; Antioxidants; Antipsychotic Agents; Dopamine Agonists; Drug Therapy; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glial Cell Line-Derived Neurotrophic Factor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Parkinson Disease; Psychotic Disorders	2002
Psychosis in Parkinson's disease: case studies. Neurologic clinics, 2006, Volume: 24, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders; Severity of Illness Index	2006
Drug-induced tardive dyskinesia. Current developments in psychopharmacology, 1981, Volume: 6 Topics: Aging; Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Psychotic Disorders; Racial Groups; Sex Factors	1981
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular psychiatry, 1998, Volume: 3, Issue:2 Topics: Antipsychotic Agents; Binding, Competitive; Cholinergic Antagonists; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Resistance; Dyskinesia, Drug-Induced; Humans; Levodopa; Ligands; Limbic System; Nerve Tissue Proteins; Parkinson Disease, Secondary; Protein Binding; Psychoses, Substance-Induced; Psychotic Disorders; Radioligand Assay; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Recurrence; Serotonin Antagonists; Tomography, Emission-Computed	1998
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation]. L'Encephale, 1979, Volume: 5, Issue:2 Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior; Corpus Striatum; Dogs; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hypothermia; Levodopa; Memory; Mice; Opioid-Related Disorders; Parkinson Disease; Psychotic Disorders; Rats; Receptors, Dopamine; Sleep; Stereotyped Behavior; Substantia Nigra; Synapses; Synaptic Transmission	1979
Drug interactions with guanidinium antihypertensives. Drugs, 1977, Volume: 13, Issue:1 Topics: Amphetamines; Anesthetics; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Contraceptives, Oral; Depression; Drug Interactions; Drug Therapy, Combination; Guanidines; Humans; Hypertension; Insulin; Levodopa; Nasal Decongestants; Psychotic Disorders; Vasoconstrictor Agents	1977
Amine precursors in neurologic disorders and the psychoses. Research publications - Association for Research in Nervous and Mental Disease, 1975, Volume: 54 Topics: Acetylcholine; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Psychoses, Substance-Induced; Psychotic Disorders	1975
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality. Psychosomatics, 1986, Volume: 27, Issue:2 Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Levodopa; Male; Mental Disorders; Nomifensine; Nortriptyline; Parkinson Disease; Personality; Psychotic Disorders; Serotonin; Tryptophan	1986

Trials

3 trial(s) available for levodopa and Psychoses

Article	Year
Dopamine-Induced Dysconnectivity Between Salience Network and Auditory Cortex in Subjects With Psychotic-like Experiences: A Randomized Double-Blind Placebo-Controlled Study. Schizophrenia bulletin, 2020, 04-10, Volume: 46, Issue:3 Topics: Adult; Auditory Cortex; Auditory Perception; Connectome; Cross-Sectional Studies; Dopamine; Dopamine Agents; Double-Blind Method; Humans; Levodopa; Magnetic Resonance Imaging; Male; Nerve Net; Psychotic Disorders; Young Adult	2020
Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Aug-15, Volume: 35, Issue:7 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clinical Trials, Phase I as Topic; Dibenzothiazepines; Disease Progression; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Inpatients; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Regional Blood Flow; Risk Factors; Time Factors; Tokyo; Tomography, Emission-Computed, Single-Photon	2011
[A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia]. Acta psiquiatrica y psicologica de America latina, 1983, Volume: 29, Issue:4 Topics: Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Placebos; Psychotic Disorders	1983

Other Studies

46 other study(ies) available for levodopa and Psychoses

Article	Year
Additive effects of mGluR Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:12 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Bridged Bicyclo Compounds; Callithrix; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Pyridines; Receptors, Metabotropic Glutamate; Serotonin 5-HT2 Receptor Antagonists; Sulfonamides	2021
Challenges in managing late-stage Parkinson's disease: Practical approaches and pitfalls. Australian journal of general practice, 2022, Volume: 51, Issue:10 Topics: Humans; Levodopa; Neurodegenerative Diseases; Pain; Parkinson Disease; Psychotic Disorders	2022
Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease. Neurobiology of disease, 2023, Volume: 176 Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Oxidopamine; Parkinson Disease; Psychotic Disorders; Quality of Life; Rats; Rats, Sprague-Dawley	2023
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis. PloS one, 2023, Volume: 18, Issue:1 Topics: Aged; Antipsychotic Agents; Dementia; Humans; Levodopa; Parkinson Disease; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea	2023
Effect of the mGlu Psychopharmacology, 2023, Volume: 240, Issue:10 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Levodopa; Parkinson Disease; Parkinsonian Disorders; Psychotic Disorders; Rats	2023
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 79 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Pramipexole; Psychotic Disorders; Quality of Life	2020
Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Disease Models, Animal; Female; Levodopa; Male; Parkinsonian Disorders; Psychotic Disorders	2021
The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset. Progress in neuro-psychopharmacology & biological psychiatry, 2018, 02-02, Volume: 81 Topics: Animals; Antidepressive Agents, Second-Generation; Callithrix; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Mianserin; MPTP Poisoning; Psychotic Disorders; Severity of Illness Index; Time Factors; Treatment Outcome	2018
Conversion Parkinson's disease with levodopa abuse and psychosis. Asian journal of psychiatry, 2017, Volume: 30 Topics: Adult; Antiparkinson Agents; Conversion Disorder; Female; Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Substance-Related Disorders	2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders. Neuropharmacology, 2018, Volume: 128 Topics: Animals; Antipsychotic Agents; Blinking; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Isoquinolines; Levodopa; Macaca mulatta; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nervous System Diseases; Prefrontal Cortex; Psychotic Disorders; Receptors, Dopamine D1; Reserpine; Sleep; Wakefulness	2018
Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study. PloS one, 2014, Volume: 9, Issue:1 Topics: Amantadine; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Delusions; Dopamine Agents; Hallucinations; Humans; Illusions; Levodopa; Logistic Models; Multivariate Analysis; Parkinson Disease; Psychotic Disorders; Risk Factors; Selegiline; Surveys and Questionnaires	2014
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting. PloS one, 2014, Volume: 9, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Female; Hematologic Tests; Humans; Levodopa; Male; Medication Adherence; Middle Aged; Nursing Homes; Parkinson Disease; Psychotic Disorders; Retrospective Studies	2014
Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Jul-15, Volume: 35, Issue:28 Topics: Adolescent; Adult; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychotic Disorders; Reaction Time; Reinforcement, Psychology; Young Adult	2015
Response to: Dopamine dysregulation syndrome and psychosis in 24-h intestinal levodopa infusion for Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 31 Topics: Antiparkinson Agents; Dopamine; Humans; Levodopa; Parkinson Disease; Psychotic Disorders	2016
Dopamine dysregulation syndrome and psychosis in 24-h intestinal levodopa infusion for Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 31 Topics: Antiparkinson Agents; Carbidopa; Dopamine; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Psychotic Disorders	2016
Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study. PloS one, 2016, Volume: 11, Issue:8 Topics: Case-Control Studies; Comorbidity; Databases, Factual; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pneumonia, Aspiration; Prognosis; Psychotic Disorders; Risk Factors; Taiwan	2016
Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome. CNS spectrums, 2016, Volume: 21, Issue:5 Topics: Antiparkinson Agents; Antipsychotic Agents; Brain; Dopamine; Humans; Levodopa; Lewy Bodies; Parkinson Disease; Piperidines; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin; Urea	2016
Feeling of presence in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:11 Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Perceptual Disorders; Psychotic Disorders; Surveys and Questionnaires	2011
Psychiatric symptoms screening in the early stages of Parkinson's disease. Journal of neurology, 2012, Volume: 259, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Levodopa; Male; Mental Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Surveys and Questionnaires	2012
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Outcome Assessment, Health Care; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index	2003
Hallucinations in Parkinson disease in the prelevodopa era. Neurology, 2006, Jan-10, Volume: 66, Issue:1 Topics: Affective Symptoms; Brain; Dementia; Dopamine; Dopamine Agents; Hallucinations; History, 19th Century; History, 20th Century; Humans; Levodopa; Neurology; Parkinson Disease; Psychotic Disorders	2006
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism & related disorders, 2006, Volume: 12, Issue:7 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders	2006
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1 Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders	2007
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior	2006
Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor. Neurochemical research, 2007, Volume: 32, Issue:10 Topics: Animals; Animals, Newborn; Antipsychotic Agents; Brain Chemistry; Catecholamines; Clozapine; Denervation; Dopamine; Dopamine Agents; Female; Haloperidol; Iron; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement Disorders; MPTP Poisoning; Norepinephrine; Pregnancy; Psychotic Disorders; Signal Transduction; Weight Gain	2007
Frégoli syndrome associated with levodopa treatment. Movement disorders : official journal of the Movement Disorder Society, 2008, Jan-30, Volume: 23, Issue:2 Topics: Antiparkinson Agents; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders; Schizophrenia, Paranoid	2008
Homozygous SCA 2 mutations changes phenotype and hastens progression. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5 Topics: Antiparkinson Agents; Ataxins; Dementia; Disease Progression; Dyskinesias; Female; Follow-Up Studies; Homozygote; Humans; Levodopa; Male; Mutation; Nerve Tissue Proteins; Ocular Motility Disorders; Parkinsonian Disorders; Phenotype; Psychotic Disorders; Spinocerebellar Degenerations	2008
Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness. The Journal of nervous and mental disease, 1980, Volume: 168, Issue:5 Topics: Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Perphenazine; Psychotic Disorders	1980
[Crises in the course of Parkinson's disease]. Wiener medizinische Wochenschrift (1946), 1980, Feb-29, Volume: 130, Issue:4 Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders	1980
Clozapine therapeutic plunge in patient with Parkinson's disease. Lancet (London, England), 1995, May-06, Volume: 345, Issue:8958 Topics: Carbidopa; Clozapine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Psychotic Disorders	1995
Portable device for quantifying parkinsonian wrist rigidity. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Psychotic Disorders; Risk Factors; Transducers	1994
Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:2 Topics: Aged; Benserazide; Blood Cell Count; Clozapine; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Paranoid Disorders; Parkinson Disease; Psychotic Disorders	1993
N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Case-Control Studies; Dopamine Agonists; Evoked Potentials, Somatosensory; Humans; Levodopa; Median Nerve; Middle Aged; Parkinson Disease; Psychotic Disorders; Reaction Time; Reference Values	1995
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 1996,Fall, Volume: 8, Issue:4 Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis	1996
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:1 Topics: Age Distribution; Age of Onset; Aged; Antiparkinson Agents; Dementia; Depression; Disease Progression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Prevalence; Psychotic Disorders; Risk Factors	2000
[Parkinson's disease]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors	2001
Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biological psychiatry, 2001, Sep-15, Volume: 50, Issue:6 Topics: Acute Disease; Adult; Antiparkinson Agents; Antipsychotic Agents; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Prospective Studies; Psychotic Disorders; Retrospective Studies; Substantia Nigra; Tomography, Emission-Computed; Ultrasonography	2001
[Treatment of reactive stuporous states with L-DOPA]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1978, Volume: 78, Issue:4 Topics: Adult; Antidepressive Agents; Catecholamines; Cognition Disorders; Consciousness Disorders; Humans; Levodopa; Middle Aged; Psychotic Disorders; Schizophrenia; Syndrome	1978
Drugs that reduce efficacy of levodopa. The New England journal of medicine, 1976, Dec-30, Volume: 295, Issue:27 Topics: Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Tranquilizing Agents	1976
[Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)]. Ceskoslovenska psychiatrie, 1976, Volume: 72, Issue:6 Topics: Amantadine; Humans; Levodopa; Mental Disorders; Parkinson Disease, Secondary; Psychotic Disorders	1976
[Treatment of Parkinson's disease associated with psychosis]. La Clinica terapeutica, 1975, Aug-15, Volume: 74, Issue:3 Topics: Aged; Female; Haloperidol; Humans; Levodopa; Parkinson Disease; Psychotic Disorders	1975
Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge. Acta endocrinologica, 1988, Volume: 117, Issue:2 Topics: Adolescent; Adrenocorticotropic Hormone; Arginine Vasopressin; Child, Preschool; Clonidine; Dinoprostone; Dopamine; Epinephrine; Female; Humans; Hypertension; Indomethacin; Levodopa; Metoclopramide; Norepinephrine; Periodicity; Prostaglandins E; Psychotic Disorders; Recurrence; Syndrome; Vomiting	1988
A therapeutic approach to tardive dyskinesia. The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2 Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors	1985
Management of catatonic stupor with L-dopa. Clinical neuropharmacology, 1988, Volume: 11, Issue:1 Topics: Antipsychotic Agents; Catatonia; Humans; Levodopa; Psychotic Disorders	1988
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders; Trihexyphenidyl	1988
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis. Clinical neuropharmacology, 1987, Volume: 10, Issue:2 Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders	1987